![](https://www.businessmarketinsights.com/assets/img/reports-icon.png)
Pronóstico del mercado de tratamiento de hematuria de América del Norte hasta 2028: impacto de COVID-19 y análisis regional por tratamiento (fármacos, terapias y otros), indicación (infecciones del tracto urinario, cálculos renales, uretritis, cáncer de sangre, cálculos en la vejiga, cáncer de próstata, cistitis, traumatismos) , ejercicio vigoroso, poliquistosis renal, endometriosis y menstruación), tipo (hematuria macroscópica, hematuria microscópica, hematuria idiopática y hematuria del corredor), usuario final (hospitales, clínicas y centros de cirugía ambulatoria, y otros)
Introducción al mercado
La hematuria es una afección médica en la que se encuentra presencia de sangre en la orina. . Generalmente, la orina no contiene glóbulos rojos y, por lo tanto, esto puede provocar problemas graves que también pueden causar cálculos renales, infecciones del tracto urinario y otras enfermedades hereditarias.
Además, la alta prevalencia de hematuria Se espera que las indicaciones asociadas refuercen el crecimiento del mercado durante el período previsto. Sin embargo, los casos no diagnosticados de indicaciones asociadas limitan el crecimiento del mercado de tratamiento de hematuria en América del Norte.
La pandemia ha ofrecido oportunidades de crecimiento vitales para los actores que operan en el mercado de enfermedades renales. Las posibilidades se debían al creciente número de pacientes afectados por el coronavirus. Por ejemplo, según el informe de la Sociedad Estadounidense de Nefrología, en respuesta al COVID-19, la mitad de los pacientes positivos al coronavirus admitidos en la unidad de cuidados intensivos (UCI) experimentan insuficiencia renal que requiere algún tipo de diálisis. El informe indicó que entre el 10% y el 50% de los pacientes en la UCI presentaban insuficiencia renal, casi el 17% de los pacientes necesitaban diálisis urgente y el 46% había mostrado alguna forma de lesión renal aguda (IRA). En toda la región de América del Norte, Estados Unidos ha registrado el mayor número de pacientes afectados por el coronavirus. Por lo tanto, un número cada vez mayor de pacientes tiene un mayor riesgo de verse afectados por una lesión renal aguda (IRA), incluida una lesión tubular con shock séptico, microinflamación, aumento de la coagulación sanguínea y una probable infección directa del riñón. Por lo tanto, se espera que aumente la demanda de productos para el control de la enfermedad renal, lo que conducirá a un crecimiento del mercado en el futuro próximo.
Descripción general y dinámica del mercado
Se prevé que el mercado del tratamiento de la hematuria en América del Norte alcance los 419,7 millones de dólares en 2028, desde los 351,6 millones de dólares de 2021; se prevé que crezca a una tasa compuesta anual del 2,6 % de 2021 a 2028. Los avances tecnológicos en dispositivos médicos y procedimientos de diagnóstico han dado lugar a varias opciones para el tratamiento de las indicaciones asociadas a la hematuria, como cálculos renales, cálculos en la vejiga e infecciones del tracto urinario. Se espera que el uso de tecnologías de tratamiento avanzadas mejore la atención al paciente. Por ejemplo, la implementación de la robótica en las cirugías para el tratamiento de la urolitiasis ha ganado popularidad en los últimos años. Actualmente, Vinci Surgical System, de Intuitive Surgical Inc., se utiliza ampliamente en la realización de cirugías para tratar la urolitiasis. De manera similar, la adopción de intervenciones endourológicas para los cálculos renales ha aumentado significativamente en varios países. También se espera que los avances en las indicaciones asociadas apoyen el mercado de tratamiento de hematuria de América del Norte durante el período de pronóstico.
Segmentos de mercado clave
En términos de tipo, el segmento de hematuria macroscópica representó la mayor parte del mercado de tratamiento de hematuria de América del Norte en 2020. En términos de tratamiento, los medicamentos El segmento representó la mayor participación del mercado de tratamiento de hematuria de América del Norte en 2020. En términos de indicación, el segmento de infecciones del tracto urinario representó la mayor participación del mercado de tratamiento de hematuria de América del Norte en 2020. En términos de usuario final, el segmento de hospitales representó la mayor participación del mercado de tratamiento de hematuria de América del Norte en 2020.
Principales fuentes y empresas incluidas
Algunas de las principales fuentes primarias y secundarias a las que se hace referencia para preparar este informe sobre el mercado del tratamiento de la hematuria en América del Norte son los sitios web de las empresas, los informes anuales, los informes financieros, los documentos del gobierno nacional y las bases de datos estadísticas. , entre otros. Las principales empresas que figuran en el informe son AstraZeneca, Bristol-Myers Squibb Company, F. HOFFMANN-LA ROCHE LTD., GlaxoSmithKline plc., Janssen Pharmaceuticals, Merck & Co., Inc., Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd y Boehringer Ingelheim International GmbH.
Informe de razones para comprar
- Comprender el panorama del mercado de tratamiento de hematuria en América del Norte e identificar segmentos de mercado que probablemente garanticen un fuerte retorno
- Para comprender el panorama del mercado en constante cambio y mantenerse a la vanguardia de la competencia
- Para Planificar de manera eficiente fusiones, adquisiciones y acuerdos de asociación en el mercado de tratamiento de hematuria de América del Norte mediante la identificación de segmentos con las ventas probables más prometedoras.
- Tomar decisiones comerciales informadas a partir de un análisis perspicaz y completo de el desempeño del mercado de varios segmentos
- Para obtener una previsión de ingresos del mercado de tratamiento de hematuria de América del Norte en función de varios segmentos para el período 2021-2028
SEGMENTACIÓN DEL MERCADO DE TRATAMIENTO DE HEMATURIA EN AMÉRICA DEL NORTE
Por Tratamiento
- Medicamentos
- Terapias
- Otras
Por indicación
- Infecciones del tracto urinario
- Cálculos renales
- Uretritis
- Cáncer de sangre
- Cálculos en la vejiga
- Cáncer de próstata
- Cistitis
- Traumatismo
- Vigoroso Ejercicio
- Enfermedad renal poliquística
- Endometriosis
- Menstruación
Por Tipo
- Hematuria macroscópica
- Hematuria microscópica
- Hematuria idiopática
- Hematuria de Jogger
Por usuario final
- Hospitales
- Clínicas
- Centros de cirugía ambulatoria (ASC)
- Otros
Por país
- América del Norte
- EE.UU.
- Canadá
- México
Empresas mencionadas
- AstraZeneca
- Compañía Bristol-Myers Squibb
- F. HOFFMANN-LA ROCHE LTD.
- GlaxoSmithKline plc.
- Janssen Pharmaceuticals
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.
- < span>Sun Pharmaceutical Industries Ltd
- Boehringer Ingelheim International GmbH
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Hematuria Treatment Market – By Treatment
1.3.2 North America Hematuria Treatment Market – By Indication
1.3.3 North America Hematuria Treatment Market – By Type
1.3.4 North America Hematuria Treatment Market – By End User
1.3.5 North America Hematuria Treatment Market – By Country
2. North America Hematuria Treatment Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Hematuria Treatment Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.3 Experts Opinion
5. Hematuria Treatment Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 High Prevalence of Hematuria-Associated Indications
5.1.2 Increasing Awareness About Treatment Options and Improving Healthcare Expenditure
5.2 Market Restraints
5.2.1 Undiagnosed Cases of Associated Indications
5.3 Market Opportunities
5.3.1 Increasing Opportunities for Related Treatments
5.4 Future Trends
5.4.1 Rise in Preference for Advanced Therapies
5.5 Impact Analysis
6. Hematuria Treatment Market – North America Analysis
6.1 North America Hematuria Treatment Market Revenue Forecast and Analysis
7. Hematuria Treatment Market Revenue and Forecast To 2028 – By Treatment
7.1 Overview
7.2 North America Hematuria Treatment Market Share by Treatment 2020 & 2028 (%)
7.3 Drugs
7.3.1 Overview
7.3.2 Drugs: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Therapies
7.4.1 Overview
7.4.2 Therapies: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
7.5 Others
7.5.1 Overview
7.5.2 Others: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8. Hematuria Treatment Market Revenue and Forecast To 2028 – By Indication
8.1 Overview
8.2 North America Hematuria Treatment Market Share by Indication 2020 & 2028 (%)
8.3 Kidney Stones
8.3.1 Overview
8.3.2 Kidney Stones: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Urinary Tract Infections (UTI)
8.4.1 Overview
8.4.2 Urinary Tract Infections: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.5 Urethritis
8.5.1 Overview
8.5.2 Urethritis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.6 Blood Cancer
8.6.1 Overview
8.6.2 Blood Cancer: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.7 Bladder Stones
8.7.1 Overview
8.7.2 Bladder Stones: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.8 Prostate Cancer
8.8.1 Overview
8.8.2 Prostate Cancer: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.9 Cystitis
8.9.1 Overview
8.9.2 Cystitis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.10 Trauma
8.10.1 Overview
8.10.2 Trauma: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.11 Vigorous Exercise
8.11.1 Overview
8.11.2 Vigorous Exercise: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.12 Polycystic Kidney Disease
8.12.1 Overview
8.12.2 Polycystic Kidney Disease: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.13 Endometriosis
8.13.1 Overview
8.13.2 Endometriosis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.14 Menstruation
8.14.1 Overview
8.14.2 Menstruation: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
9. Hematuria Treatment Market Revenue and Forecast To 2028 – By Type
9.1 Overview
9.2 North America Hematuria Treatment Market, By Type 2020 & 2028 (%)
9.3 Macroscopic Hematuria
9.3.1 Overview
9.3.2 Macroscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
9.4 Microscopic Hematuria
9.4.1 Overview
9.4.2 Microscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
9.5 Idiopathic Hematuria
9.5.1 Overview
9.5.2 Idiopathic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
9.6 Jogger’s Hematuria
9.6.1 Overview
9.6.2 Jogger’s Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
10. Hematuria Treatment Market Revenue and Forecast To 2028 – By End User
10.1 Overview
10.2 North America Hematuria Treatment Market Share by End User 2020 & 2028 (%)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
10.4 Clinics
10.4.1 Overview
10.4.2 Clinics: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
10.5 Ambulatory Surgical Centers (ASC’s)
10.5.1 Overview
10.5.2 Ambulatory Surgical Centers: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
10.6 Others
10.6.1 Overview
10.6.2 Others: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
11. North America Hematuria Treatment Market – Geographic Analysis
11.1 North America: Hematuria Treatment Market
11.1.1 Overview
11.1.2 North America: Hematuria Treatment Market, by Country, 2021 & 2028 (%)
11.1.2.1 US: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.1.1 US: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.1.2 US: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
11.1.2.1.3 US: Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
11.1.2.1.4 US: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
11.1.2.1.5 US: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.1.2.2 Canada: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.2.1 Canada: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.2.2 Canada: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
11.1.2.2.3 Canada: Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
11.1.2.2.4 Canada: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
11.1.2.2.5 Canada: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.1.2.3 Mexico: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.3.1 Mexico: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.3.2 Mexico: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
11.1.2.3.3 Mexico: Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
11.1.2.3.4 Mexico: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
11.1.2.3.5 Mexico: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)
12. Impact Of COVID-19 Pandemic on Hematuria Treatment Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
13. Hematuria Treatment Market–Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. Company Profiles
14.1 AstraZeneca
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Bristol-Myers Squibb Company
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 F. HOFFMANN-LA ROCHE LTD.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 GlaxoSmithKline Plc
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Janssen Pharmaceuticals
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Merck & Co., Inc.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Novartis AG
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Pfizer Inc.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Sun Pharmaceutical Industries Ltd
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Boehringer Ingelheim International GmbH
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. US: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 2. US: Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 3. US: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 4. US: Hematuria Treatment Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)
Table 5. Canada: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 6. Canada: Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 7. Canada: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 8. Canada: Hematuria Treatment Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)
Table 9. Mexico: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 10. Mexico: Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 11. Mexico: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 12. Mexico: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 13. Organic Developments Done by Companies
Table 14. Inorganic Developments Done by Companies
Table 15. Glossary of Terms, Hematuria Treatment Market
LIST OF FIGURES
Figure 1. Hematuria Treatment Market Segmentation
Figure 2. North America Hematuria Treatment Market Overview
Figure 3. Macroscopic Hematuria Segment Held the Largest Share of the Type Segment in Hematuria Treatment Market
Figure 4. US to Show Significant Growth During Forecast Period
Figure 5. North America Hematuria Treatment Market, Industry Landscape
Figure 6. North America PEST Analysis
Figure 7. Hematuria Treatment Market Impact Analysis of Drivers and Restraints
Figure 8. North America Hematuria Treatment Market – Revenue Forecast and Analysis – 2020- 2028
Figure 9. North America Hematuria Treatment Market Share by Treatment 2020 & 2028 (%)
Figure 10. Drugs: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 11. Therapies: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 12. Others: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 13. North America Hematuria Treatment Market Share by Indication 2020 & 2028 (%)
Figure 14. Kidney Stones: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 15. Urinary Tract Infections: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 16. Urethritis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 17. Blood Cancer: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 18. Bladder Stones: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 19. Prostate Cancer: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 20. Cystitis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 21. Trauma: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 22. Vigorous Exercise: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 23. Polycystic Kidney Disease: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 24. Endometriosis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 25. Menstruation: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 26. North America Hematuria Treatment Market, by Type 2020 & 2028 (%)
Figure 27. Macroscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 28. Microscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 29. Idiopathic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 30. Jogger’s Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 31. North America Hematuria Treatment Market Share by End User 2020 & 2028 (%)
Figure 32. Hospitals: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 33. Clinics: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 34. Ambulatory Surgical Centers: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 35. Others: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 36. North America: Hematuria Treatment Market, by Key Country – Revenue (2021) (USD Million)
Figure 37. North America: Hematuria Treatment Market, by Country, 2021 & 2028 (%)
Figure 38. US: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 39. Canada: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 40. Mexico: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 41. Impact Of COVID-19 Pandemic in North America Country Markets
Figure 42. Growth Strategies Done by the Companies in the Market, (%)
- AstraZeneca
- Bristol-Myers Squibb Company
- F. HOFFMANN-LA ROCHE LTD.
- GlaxoSmithKline plc.
- Janssen Pharmaceuticals
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.
- Sun Pharmaceutical Industries Ltd
- Boehringer Ingelheim International GmbH
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America hematuria treatment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America hematuria treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.